Proton pump inhibitors: actions and reactions
James M Mullin1, Melissa Gabello, Lisa J Murray
1Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096-3450, USA. MullinJ@MLHS.org
Proton pump inhibitors (PPIs) are widely used for acid-related disorders. While effective, their use may cause unintended physiological changes in the upper gastrointestinal tract and beyond.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Proton pump inhibitors (PPIs) are the second most prescribed drug class in the U.S.
- Increased PPI use correlates with rising rates of reflux disease.
- PPIs have largely replaced H-2 receptor antagonists due to efficacy and lack of tachyphylaxis.
Purpose of the Study:
- To explore potential undesired physiological effects of PPIs.
- To investigate non-gastric effects linked to H(+), K(+)-ATPase ubiquity.
- To examine PPI influence on upper GI tract physiology.
Main Methods:
- Review of current literature on PPI utilization and effects.
- Analysis of physiological alterations induced by elevated intragastric pH.
- Examination of H(+), K(+)-ATPase distribution and function.
Main Results:
- PPIs elevate intragastric pH, altering gastric physiology.
- Widespread H(+), K(+)-ATPase may lead to non-gastric effects.
- PPIs can potentially induce transepithelial leak.
Conclusions:
- The widespread use of PPIs necessitates understanding their full physiological impact.
- Potential for off-target effects warrants further investigation.
- PPIs may influence gastrointestinal and potentially other organ systems.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
